Comparative phosphoproteomic analysis of checkpoint recovery identifies new regulators of the DNA damage response

Science Signaling

Volumn 6, Issue 272, 2013, Pages

  Halim, Vincentius A ^a,b,c   Alvarez Fernández, Mónica ^a,d   Xu, Yan Juan ^e   Aprelia, Melinda ^e   Van Den Toorn, Henk W P ^b,c   Heck, Albert J R ^b,c   Mohammed, Shabaz ^b,c   Medema, René H ^a,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

^d Structural Biology and Biocomputing Programme   (Spain)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; PROTEIN ASTRIN; PROTEIN MDM2; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; ASTRINGENCY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DNA DAMAGE CHECKPOINT; MITOSIS SPINDLE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; RNA INTERFERENCE;

CELL LINE, TUMOR; DNA DAMAGE; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MITOTIC SPINDLE APPARATUS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEOMICS; RNA, SMALL INTERFERING;

MURINAE;

EID: 84876818831     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003664     Document Type: Article

References (53)

1. 2/M transition. Biochim. Biophys. Acta 1519, 1-12 (2001).
2. J. Bartek, J. Lukas, DNA damage checkpoints: From initiation to recovery or adaptation. Curr. Opin. Cell Biol. 19, 238-245 (2007).
3. M. A. van Vugt, M. B. Yaffe, Cell cycle re-entry mechanisms after DNA damage checkpoints: Giving it some gas to shut off the breaks! Cell Cycle 9, 2097-2101 (2010).
4. M. Alvarez-Fernández, V. A. Halim, L. Krenning, M. Aprelia, S. Mohammed, A. J. Heck, R. H. Medema, Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1. EMBO Rep. 11, 452-458 (2010).
5. L. Macurek, A. Lindqvist, D. Lim, M. A. Lampson, R. Klompmaker, R. Freire, C. Clouin, S. S. Taylor, M. B. Yaffe, R. H. Medema, Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 455, 119-123 (2008).
6. M. A. van Vugt, A. Brás, R. H. Medema, Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol. Cell 15, 799-811 (2004).
7. A. Seki, J. A. Coppinger, C. Y. Jang, J. R. Yates, G. Fang, Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science 320, 1655-1658 (2008).
8. R. A. Donnianni, M. Ferrari, F. Lazzaro, M. Clerici, B. Tamilselvan Nachimuthu, P. Plevani, M. Muzi-Falconi, A. Pellicioli, Elevated levels of the Polo kinase Cdc5 override the Mec1/ ATR checkpoint in budding yeast by acting at different steps of the signaling pathway. PLoS Genet. 6, e1000763 (2010).
9. βTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol. Cell 23, 307-318 (2006).
10. I. Mamely, M. A. van Vugt, V. A. Smits, J. I. Semple, B. Lemmens, A. Perrakis, R. H. Medema, R. Freire, Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery. Curr. Biol. 16, 1950-1955 (2006).
11. βTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol. Cell 23, 319-329 (2006).
12. 2/M DNA damage checkpoint. PLoS Biol. 8, e1000287 (2010).
13. G. M. Vidanes, F. D. Sweeney, S. Galicia, S. Cheung, J. P. Doyle, D. Durocher, D. P. Toczyski, CDC5 inhibits the hyperphosphorylation of the checkpoint kinase Rad53, leading to checkpoint adaptation. PLoS Biol. 8, e1000286 (2010).
14. V. Dulic, W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, S. I. Reed, p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013-1023 (1994).
15. W. S. el-Deiry, T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
16. Y. Xiong, G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, D. Beach, p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704 (1993).
17. 2/M promoters. Mol. Cell. Biol. 25, 3737-3751 (2005).
18. S. A. Innocente, J. M. Lee, p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription. FEBS Lett. 579, 1001-1007 (2005).
19. K. Krause, U. Haugwitz, M. Wasner, M.Wiedmann, J. Mössner, K. Engeland, Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73. Biochem. Biophys. Res. Commun. 284, 743-750 (2001).
20. K. Krause, M. Wasner, W. Reinhard, U. Haugwitz, C. L. Dohna, J. Mössner, K. Engeland, The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res. 28, 4410-4418 (2000).
21. A. Lindqvist, M. de Bruijn, L. Macurek, A. Brás, A. Mensinga, W. Bruinsma, O. Voets, O. Kranenburg, R. H. Medema, Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. EMBO J. 28, 3196-3206 (2009).
22. 2 arrest. J. Biol. Chem. 276, 5570-5576 (2001).
23. 2 arrest after DNA damage. Science 282, 1497-1501 (1998).
24. N. Dephoure, C. Zhou, J. Villén, S. A. Beausoleil, C. E. Bakalarski, S. J. Elledge, S. P. Gygi, A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 105, 10762-10767 (2008).
25. J. V. Olsen, M. Vermeulen, A. Santamaria, C. Kumar, M. L. Miller, L. J. Jensen, F. Gnad, J. Cox, T. S. Jensen, E. A. Nigg, S. Brunak, M. Mann, Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 3, ra3 (2010).
26. S. Matsuoka, B. A. Ballif, A. Smogorzewska, E. R. McDonald III, K. E. Hurov, J. Luo, C. E. Bakalarski, Z. Zhao, N. Solimini, Y. Lerenthal, Y. Shiloh, S. P. Gygi, S. J. Elledge, ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160-1166 (2007).
27. P. J. Boersema, R. Raijmakers, S. Lemeer, S. Mohammed, A. J. Heck, Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat. Protoc. 4, 484-494 (2009).
28. S. Gauci, A. O. Helbig, M. Slijper, J. Krijgsveld, A. J. Heck, S. Mohammed, Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal. Chem. 81, 4493-4501 (2009).
29. 2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster. J. Proteome Res. 7, 687-697 (2008).
30. R. Raijmakers, C. R. Berkers, A. de Jong, H. Ovaa, A. J. Heck, S. Mohammed, Automated online sequential isotope labeling for protein quantitation applied to proteasome tissue-specific diversity. Mol. Cell. Proteomics 7, 1755-1762 (2008).
31. D. M. Lowery, K. R. Clauser, M. Hjerrild, D. Lim, J. Alexander, K. Kishi, S. E. Ong, S. Gammeltoft, S. A. Carr, M. B. Yaffe, Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrate. EMBO J. 26, 2262-2273 (2007).
32. R. Linding, L. J. Jensen, G. J. Ostheimer, M. A. van Vugt, C. Jørgensen, I. M. Miron, F. Diella, K. Colwill, L. Taylor, K. Elder, P. Metalnikov, V. Nguyen, A. Pasculescu, J. Jin, J. G. Park, L. D. Samson, J. R. Woodgett, R. B. Russell, P. Bork, M. B. Yaffe, T. Pawson, Systematic discovery of in vivo phosphorylation networks. Cell 129, 1415-1426 (2007).
33. T. Weinert, DNA damage checkpoints update: Getting molecular. Curr. Opin. Genet. Dev. 8, 185-193 (1998).
34. M. S. Chang, C. J. Huang, M. L. Chen, S. T. Chen, C. C. Fan, J. M. Chu, W. C. Lin, Y. C. Yang, Cloning and characterization of hMAP126, a new member of mitotic spindle-associated proteins. Biochem. Biophys. Res. Commun. 287, 116-121 (2001).
35. G. J. Mack, D. A. Compton, Analysis of mitotic microtubule-associated proteins using mass spectrometry identifies astrin, a spindle-associated protein. Proc. Natl. Acad. Sci. U.S.A. 98, 14434-14439 (2001).
36. A. N. Kettenbach, D. K. Schweppe, B. K. Faherty, D. Pechenick, A. A. Pletnev, S. A. Gerber, Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci. Signal. 4, rs5 (2011).
37. J. Du, S. Jablonski, T. J. Yen, G. J. Hannon, Astrin regulates Aurora-A localization. Biochem. Biophys. Res. Commun. 370, 213-219 (2008).
38. A. Santamaria, B.Wang, S. Elowe, R. Malik, F. Zhang, M. Bauer, A. Schmidt, H. H. Silljé, R. Körner, E. A. Nigg, The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol. Cell. Proteomics 10, M110.004457 (2011).
39. A. K. Dunsch, E. Linnane, F. A. Barr, U. Gruneberg, The astrin-kinastrin/SKAP complex localizes to microtubule plus ends and facilitates chromosome alignment. J. Cell Biol. 192, 959-968 (2011).
40. F. S. Oppermann, K. Grundner-Culemann, C. Kumar, O. J. Gruss, P. V. Jallepalli, H. Daub, Combination of chemical genetics and phosphoproteomics for kinase signaling analysis enables confident identification of cellular downstream targets. Mol. Cell. Proteomics 11, O111.012351 (2012).
41. Y. C. Yang, Y. T. Hsu, C. C. Wu, H. T. Chen, M. S. Chang, Silencing of astrin induces the p53-dependent apoptosis by suppression of HPV18 E6 expression and sensitizes cells to paclitaxel treatment in HeLa cells. Biochem. Biophys. Res. Commun. 343, 428-434 (2006).
42. E. Batchelor, C. S. Mock, I. Bhan, A. Loewer, G. Lahav, Recurrent initiation: A mechanism for triggering p53 pulses in response to DNA damage. Mol. Cell 30, 277-289 (2008).
43. J. E. Toettcher, A. Loewer, G. J. Ostheimer, M. B. Yaffe, B. Tidor, G. Lahav, Distinct mechanisms act in concert to mediate cell cycle arrest. Proc. Natl. Acad. Sci. U.S.A. 106, 785-790 (2009).
44. R. Lev Bar-Or, R. Maya, L. A. Segel, U. Alon, A. J. Levine, M. Oren, Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study. Proc. Natl. Acad. Sci. U.S.A. 97, 11250-11255 (2000).
45. A. L. Manning, S. F. Bakhoum, S. Maffini, C. Correia-Melo, H. Maiato, D. A. Compton, CLASP1, astrin and Kif2b form a molecular switch that regulates kinetochore-microtubule dynamics to promote mitotic progression and fidelity. EMBO J. 29, 3531-3543 (2010).
46. K. H. Thein, J. Kleylein-Sohn, E. A. Nigg, U. Gruneberg, Astrin is required for the maintenance of sister chromatid cohesion and centrosome integrity. J. Cell Biol. 178, 345-354 (2007).
47. L. Liu, S. Akhter, J. B. Bae, S. S. Mukhopadhyay, C. T. Richie, X. Liu, R. Legerski, SNM1B/Apollo interacts with Astrin and is required for the prophase cell cycle checkpoint. Cell Cycle 8, 628-638 (2009).
48. X. S. Liu, H. Li, B. Song, X. Liu, Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery. EMBO Rep. 11, 626-632 (2010).
49. G. Lahav, N. Rosenfeld, A. Sigal, N. Geva-Zatorsky, A. J. Levine, M. B. Elowitz, U. Alon, Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat. Genet. 36, 147-150 (2004).
50. J. J. Benschop, S. Mohammed, M. O'Flaherty, A. J. Heck, M. Slijper, F. L. Menke, Quantitative phosphoproteomics of early elicitor signaling in Arabidopsis. Mol. Cell. Proteomics 6, 1198-1214 (2007).
51. H. W. van den Toorn, J. Muñoz, S. Mohammed, R. Raijmakers, A. J. Heck, B. van Breukelen, RockerBox: Analysis and filtering of massive proteomics search results. J. Proteome Res. 10, 1420-1424 (2011).
52. P. Mortensen, J. W. Gouw, J. V. Olsen, S. E. Ong, K. T. Rigbolt, J. Bunkenborg, J. Cox, L. J. Foster, A. J. Heck, B. Blagoev, J. S. Andersen, M. Mann, MSQuant, an open source platform for mass spectrometry-based quantitative proteomics. J. Proteome Res. 9, 393-403 (2010).
53. M. Alvarez-Fernandez, V. A. Halim, M. Aprelia, J. Laoukili, S. Mohammed, R. H. Medema, Protein phosphatase 2A (B55α) prevents premature activation of forkhead transcription factor FoxM1 by antagonizing cyclin A/cyclin-dependent kinase-mediated phosphorylation. J. Biol. Chem. 286, 33029-33036 (2011).